← 產業報告目錄
Phenobarbital Market Size, Share & Trends Analysis Report By Indication (Epilepsy, Neonatal seizures), By Dosage Form (Tablets, Injectable, Formulations), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And by Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-31頁數 180報告編號 INSIGHTACE-c8657488ea
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Phenobarbital Market on a global scale was estimated at USD 1.48 Bn in 2022 and is forecasted to attain USD 2.20 Bn by 2031, with a projected CAGR of 4.6% between 2023 and 2031.
Phenobarbital covers reshaping how healthcare entities approach this space.
The market's upward path is bolstered by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Phenobarbital Market Snapshot
Chapter 4. Global Phenobarbital Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Indication Estimates & Trend Analysis
5.1. By Indication, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Indication:
5.2.1. Epilepsy
5.2.2. Neonatal Seizures
Chapter 6. Market Segmentation 2: By Dosage Form Estimates & Trend Analysis
6.1. By Dosage Form & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Dosage Form:
6.2.1. Tablets
6.2.2. Injectable Formulations
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Distribution Channel & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Distribution Channel:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Phenobarbital Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Phenobarbital Market revenue (US$ Million) estimates and forecasts By Indication, 2019-2031
8.1.2. North America Phenobarbital Market revenue (US$ Million) estimates and forecasts By Dosage Form, 2019-2031
8.1.3. North America Phenobarbital Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031
8.1.4. North America Phenobarbital Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Phenobarbital Market revenue (US$ Million) By Indication, 2019-2031
8.2.2. Europe Phenobarbital Market revenue (US$ Million) By Dosage Form, 2019-2031
8.2.3. Europe Phenobarbital Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.2.4. Europe Phenobarbital Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Phenobarbital Market revenue (US$ Million) By Indication, 2019-2031
8.3.2. Asia Pacific Phenobarbital Market revenue (US$ Million) By Dosage Form, 2019-2031
8.3.3. Asia Pacific Phenobarbital Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.3.4. Asia Pacific Phenobarbital Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Phenobarbital Market revenue (US$ Million) By Indication, (US$ Million) 2019-2031
8.4.2. Latin America Phenobarbital Market revenue (US$ Million) By Dosage Form, (US$ Million) 2019-2031
8.4.3. Latin America Phenobarbital Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.4.4. Latin America Phenobarbital Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Phenobarbital Market revenue (US$ Million) By Indication, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Phenobarbital Market revenue (US$ Million) By Dosage Form, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Phenobarbital Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Phenobarbital Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Sanofi
9.2.2. Pfizer Inc.
9.2.3. Novartis AG
9.2.4. Teva Pharmaceutical Industries Ltd.
9.2.5. Mylan N.V.
9.2.6. Sun Pharmaceutical Industries Ltd.
9.2.7. Hikma Pharmaceuticals
9.2.8. Zydus Cadila
9.2.9. Lannett Company, Inc.
9.2.10. Strides Pharma Science Limited
9.2.11. Cipla Ltd.
9.2.12. Lupin Limited
9.2.13. Aurobindo Pharma Limited
9.2.14. Torrent Pharmaceuticals Ltd.
9.2.15. Reddy's Laboratories Ltd..
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們